Fulcrum Therapeutics, Inc. FULC
3.69 USD -0.02 (-0.54%)
Regular-session close
3.68 -0.01 -0.27%
After hours · Nov 20, 4:07 PM ET
3.68 Day range 3.73
3.14 52-week range 14.60
- YTD
- -67.37%
- 1 year
- -66.64%
FULC revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | -80,000,000 | -100.00% |
| FY 2024 | 2024-12-31 | 80,000,000 | 77,195,000 | 2752.05% |
| FY 2023 | 2023-12-31 | 2,805,000 | -3,537,000 | -55.77% |
| FY 2022 | 2022-12-31 | 6,342,000 | -12,821,000 | -66.90% |
| FY 2021 | 2021-12-31 | 19,163,000 | 10,340,000 | 117.19% |
| FY 2020 | 2020-12-31 | 8,823,000 | 8,823,000 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-15T07:00:36.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
